| Preeclampsia: an endothelial cell disorder JM Roberts, RN Taylor, TJ Musci, GM Rodgers, CA Hubel, ... American journal of obstetrics and gynecology 161 (5), 1200-1204, 1989 | 2535 | 1989 |
| A cell-based model of hemostasis M Hoffman, DM Monroe III Thrombosis and haemostasis 85 (06), 958-965, 2001 | 2128 | 2001 |
| Wintrobe's clinical hematology JP Greer, DA Arber, B Glader, AF List, RT Means, F Paraskevas, ... Lippincott Williams & Wilkins, 2013 | 1357 | 2013 |
| Evidence of increased angiogenesis in patients with acute myeloid leukemia JW Hussong, GM Rodgers, PJ Shami Blood, The Journal of the American Society of Hematology 95 (1), 309-313, 2000 | 663 | 2000 |
| Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells GM Rodgers, MT Conn | 628 | 1990 |
| Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. GM Rodgers, WH Kane The Journal of clinical investigation 77 (6), 1909-1916, 1986 | 576 | 1986 |
| Hyperhomocysteinemia and venous thrombosis: a meta-analysis M Den Heijer, FR Rosendaal, HJ Blom, WBJ Gerrits, GMJ Bos Thrombosis and haemostasis 80 (12), 874-877, 1998 | 559 | 1998 |
| Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. RH Fryer, BD Wilson, DB Gubler, LA Fitzgerald, GM Rodgers Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 13 (9), 1327-1333, 1993 | 505 | 1993 |
| Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease G Merli, TE Spiro, CG Olsson, U Abildgaard, BL Davidson, A Eldor, ... Annals of internal medicine 134 (3), 191-202, 2001 | 454 | 2001 |
| Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells GM Rodgers, RN Taylor, JM Roberts American journal of obstetrics and gynecology 159 (4), 908-914, 1988 | 449 | 1988 |
| Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis MM Rees, GM Rodgers Thrombosis research 71 (5), 337-359, 1993 | 352 | 1993 |
| The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome O Amengual, T Atsumi, MA Khamashta, GRV Hughes Thrombosis and haemostasis 79 (02), 276-281, 1998 | 346 | 1998 |
| Parenteral iron therapy options SB Silverstein, GM Rodgers American journal of hematology 76 (1), 74-78, 2004 | 339 | 2004 |
| Cancer-and chemotherapy-induced anemia GM Rodgers, PS Becker, M Blinder, D Cella, A Chanan-Khan, C Cleeland, ... Journal of the National Comprehensive Cancer Network 10 (5), 628-653, 2012 | 281 | 2012 |
| Hemostatic properties of normal and perturbed vascular cells GM Rodgers The FASEB journal 2 (2), 116-123, 1988 | 265 | 1988 |
| Diagnosis and treatment of cancer‐related anemia JA Gilreath, DD Stenehjem, GM Rodgers American journal of hematology 89 (2), 203-212, 2014 | 254 | 2014 |
| Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. RH Fryer, EP Schwobe, ML Woods, GM Rodgers Journal of Investigative Medicine: the Official Publication of the American …, 1997 | 251 | 1997 |
| Lupus anticoagulant in the acquired immunodeficiency syndrome EJ Bloom, DI Abrams, G Rodgers Jama 256 (4), 491-493, 1986 | 229 | 1986 |
| Disseminated intravascular coagulation: clinical and laboratory aspects MJ Carey, GM Rodgers American journal of hematology 59 (1), 65-73, 1998 | 223 | 1998 |
| The D‐dimer assay ED Johnson, JC Schell, GM Rodgers American journal of hematology 94 (7), 833-839, 2019 | 218 | 2019 |
